In Reply

Brandi et al. clarify data about the localization of human equilibrative nucleoside transporter 1 in cancer patients receiving gemcitabine‐based chemotherapy. They discuss methodology, differences between antibodies, and recommendations for further study.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2016-12, Vol.21 (12), p.e5-e6
Hauptverfasser:	Brandi, Giovanni, Deserti, Marzia, Vasuri, Francesco, Farioli, Andrea, Degiovanni, Alessio, Palloni, Andrea, Frega, Giorgio, Barbera, Maria A., Lorenzo, Stefania, Garajova, Ingrid, Di Marco, Mariacristina, Pinna, Antonio D., Cescon, Matteo, Cucchetti, Alessandro, Ercolani, Giorgio, D'Errico‐Grigioni, Antonietta, Pantaleo, Maria A., Biasco, Guido, Tavolari, Simona, Aprile, Giuseppe, Cereda, Stefano, Fornaro, Lorenzo, Leone, Francesco, Lonardi, Sara, Santini, Daniele, Silvestris, Nicola, Vasile, Enrico
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Brandi et al. clarify data about the localization of human equilibrative nucleoside transporter 1 in cancer patients receiving gemcitabine‐based chemotherapy. They discuss methodology, differences between antibodies, and recommendations for further study.
ISSN:	1083-7159 1549-490X
DOI:	10.1634/theoncologist.2016-0286